[ad_1] OSLO, Norway, Oct. 10, 2024 /PRNewswire/ — Oncoinvent, a clinical stage, radiopharmaceutical company developing innovative treatments for solid cancers, today announced that the first patient has been dosed in its Phase 2 study of […]
#Rosal Top Picks
Recent Posts
- [ad_1] BANGALORE, India, Feb. 13, 2025 /PRNewswire/
- [ad_1] Battery Separator Films Market is Segmented by
- [ad_1] Expansion Across Seven Brands, Strategic
- [ad_1] BENGALURU, India, Feb. 13, 2025 /PRNewswire/
- [ad_1] Physicians within North American’s
